TrialNature cancer2026

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial.

Guangwen Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.